Maher, S., Jjunju, F. P. M. & Taylor, S. Colloquium: 100 years of mass spectrometry: perspectives and future trends. Rev. Mod. Phys. 87, 113–135 (2015).
Griffiths, J. A brief history of mass spectrometry. Anal. Chem. 80, 5678–5683 (2008).
Article CAS PubMed Google Scholar
Parkins, W. & E, W. The uranium bomb, the calutron, and the space-charge problem. Phys. Today 58, 45–51 (2005).
Pitt, J. J. Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin. Biochem. Rev. 30, 19–34 (2009).
PubMed PubMed Central Google Scholar
Aebersold, R. & Mann, M. Mass spectrometry-based proteomics. Nature 422, 198–207 (2003).
Article CAS PubMed Google Scholar
Nkuipou-Kenfack, E., Zurbig, P. & Mischak, H. The long path towards implementation of clinical proteomics: exemplified based on CKD273. Proteomics Clin. Appl. 11 (2017).
Roos, A., Thompson, R., Horvath, R., Lochmuller, H. & Sickmann, A. Intersection of proteomics and genomics to “solve the unsolved” in rare disorders such as neurodegenerative and neuromuscular diseases. Proteomics Clin. Appl. 12 (2018).
Braconi, D., Bernardini, G., Spiga, O. & Santucci, A. Leveraging proteomics in orphan disease research: pitfalls and potential. Expert Rev. Proteom. 18, 315–327 (2021).
Chantada-Vazquez, M. D. P., Bravo, S. B., Barbosa-Gouveia, S., Alvarez, J. V. & Couce, M. L. Proteomics in inherited metabolic disorders. Int. J. Mol. Sci. 23, 14744 (2022).
Suran, M. After the genome-a brief history of proteomics. JAMA 328, 1168–1169 (2022).
Hartin, S. N., Means, J. C., Alaimo, J. T. & Younger, S. T. Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics. Mol. Med. 26, 117 (2020).
Article PubMed PubMed Central Google Scholar
Wojcik, M. H. et al. Genome sequencing for diagnosing rare diseases. N. Engl. J. Med. 390, 1985–1997 (2024).
Article CAS PubMed PubMed Central Google Scholar
Kopajtich, R. et al. Integration of proteomics with genomics and transcriptomics increases the diagnostic rate of Mendelian disorders. Preprint at medRxiv 2021.03.09.21253187 (2021).
Hock, D. H. et al. Untargeted proteomics enables ultra-rapid variant prioritization in mitochondrial and other rare diseases. Preprint at medRxiv 2024.08.06.24311318 (2024).
Cui, M., Cheng, C. & Zhang, L. High-throughput proteomics: a methodological mini-review. Lab Invest. 102, 1170–1181 (2022).
Article PubMed PubMed Central Google Scholar
Fredriksson, S. et al. Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20, 473–477 (2002).
Article CAS PubMed Google Scholar
Rodari, M. M. et al. Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options. J. Clin. Immunol. 43, 1403–1413 (2023).
Article CAS PubMed PubMed Central Google Scholar
Yu, F. et al. Loss of the TRPM4 channel in humans causes immune dysregulation with defective monocyte migration. J. Allergy Clin. Immunol. 154, 792–806 (2024).
Article CAS PubMed Google Scholar
Deng, Y. T. et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188, 253–271.e7 (2024).
Stark, Z. et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet. Med. 18, 1090–1096 (2016).
Article CAS PubMed Google Scholar
Tan, T. Y. et al. Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions. JAMA Pediatr. 171, 855–862 (2017).
Article PubMed PubMed Central Google Scholar
Stark, Z. et al. Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. Am. J. Hum. Genet. 110, 419–426 (2023).
Article CAS PubMed PubMed Central Google Scholar
Kremer, L. S. et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat. Commun. 8, 15824 (2017).
Article CAS PubMed PubMed Central Google Scholar
Yépez, V. A. et al. Detection of aberrant gene expression events in RNA sequencing data. Nat. Protoc. 16, 1276–1296 (2021).
Alston, C. L. et al. Bi-allelic mutations in NDUFA6 establish its role in early-onset isolated mitochondrial complex I deficiency. Am. J. Hum. Genet. 103, 592–601 (2018).
Article CAS PubMed PubMed Central Google Scholar
Sbardella, D. et al. Defective proteasome biogenesis into skin fibroblasts isolated from Rett syndrome subjects with MeCP2 non-sense mutations. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165793 (2020).
Article CAS PubMed Google Scholar
Frazier, A. E. et al. Fatal perinatal mitochondrial cardiac failure caused by recurrent de novo duplications in the ATAD3 locus. Med 2, 49–73 (2021).
Article CAS PubMed Google Scholar
Helman, G. et al. Multiomic analysis elucidates Complex I deficiency caused by a deep intronic variant in NDUFB10. Hum. Mutat. 42, 19–24 (2021).
Article CAS PubMed Google Scholar
Sathe, G. et al. Ethylmalonic encephalopathy ETHE1 p. D165H mutation alters the mitochondrial function in human skeletal muscle proteome. Mitochondrion 58, 64–71 (2021).
Article CAS PubMed Google Scholar
Lee, R. G. et al. Deleterious variants in CRLS1 lead to cardiolipin deficiency and cause an autosomal recessive multi-system mitochondrial disease. Hum. Mol. Genet. 31, 3597–3612 (2022).
Rahman, S. Leigh syndrome. Handb. Clin. Neurol. 194, 43–63 (2023).
Lake, N. J. et al. Biallelic mutations in MRPS34 lead to instability of the small mitoribosomal subunit and Leigh syndrome. Am. J. Hum. Genet. 101, 239–254 (2017).
Article CAS PubMed PubMed Central Google Scholar
Alahmad, A. et al. Bi-allelic pathogenic variants in NDUFC2 cause early-onset Leigh syndrome and stalled biogenesis of complex I. EMBO Mol. Med. 12, e12619 (2020).
Article CAS PubMed PubMed Central Google Scholar
Alston, C. L. et al. Pathogenic bi-allelic mutations in NDUFAF8 cause Leigh syndrome with an isolated complex I deficiency. Am. J. Hum. Genet. 106, 92–101 (2020).
Article CAS PubMed Google Scholar
Feldkirchner, S. et al. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy. Neuromuscul. Disord. 23, 418–426 (2013).
Van Bergen, N. J. et al. Mutations in the exocyst component EXOC2 cause severe defects in human brain development. J. Exp. Med. 217, e20192040 (2020).
Foehr, R., Anderson, K., Dombrowski, O., Foehr, A. & Foehr, E. D. Dysregulation of extracellular matrix and lysyl oxidase in Ehlers-Danlos syndrome type IV skin fibroblasts. Orphanet J. Rare Dis. 19, 9 (2024).
Article PubMed PubMed Central Google Scholar
Lunke, S. et al. Integrated multi-omics for rapid rare disease diagnosis on a national scale. Nat. Med. 29, 1681–1691 (2023).
Amarasekera, S. S. C. et al. Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. Hum. Mol. Genet. 32, 2441–2454 (2023).
Article CAS PubMed PubMed Central Google Scholar
Bakhshalizadeh, S. et al. Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency. Hum. Genet. 142, 879–907 (2023).
Comments (0)